Quality of life, long-term survivors and long-term outcome from the ABC-02 study

748TiPABC-06: A RANDOMISED PHASE III, MULTI-CENTRE, OPEN-LABEL STUDY OF ACTIVE SYMPTOM CONTROL (ASC) ALONE OR ASC WITH OXALIPLATIN / 5-FU CHEMOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED / METASTATIC BILIARY TRACT CANCERS (ABC) PREVIOUSLY TREATED WITH CISPLATIN / GEMCITABINE CHEMOTHERAPY.

(2017) A. Lamarca et al.   ANNALS OF ONCOLOGY

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

(2013) J. W. Valle et al.   ANNALS OF ONCOLOGY

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

(2013) Yuchen Jiao et al.   NATURE GENETICS

Relationship Between Deficits in Overall Quality of Life and Non–Small-Cell Lung Cancer Survival

(2012) Jeff A. Sloan et al.   JOURNAL OF CLINICAL ONCOLOGY

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2011) F. Eckel et al.   ANNALS OF ONCOLOGY

Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21

(2011) E Friend et al.   BRITISH JOURNAL OF CANCER

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

(2010) T Okusaka et al.   BRITISH JOURNAL OF CANCER

Pain and Emotional Well-Being Outcomes in Southwest Oncology Group–Directed Intergroup Trial S0205: A Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine As First-Line Therapy in Patients With Advanced Pancreas Cancer

(2010) Carol M. Moinpour et al.   JOURNAL OF CLINICAL ONCOLOGY

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study – The UK ABC-01 Study

(2009) J W Valle et al.   BRITISH JOURNAL OF CANCER